Immunohistochemical-based diagnosis of lung adenocarcinoma subtypes reproduces the results of gene expression profiling.
A. S. Lucas
No relevant relationships to disclose
M. D. Wilkerson
No relevant relationships to disclose
P. J. Roberts
No relevant relationships to disclose
M. C. Hayward
No relevant relationships to disclose
J. E. Grilley-Olson
No relevant relationships to disclose
T. Stinchcombe
No relevant relationships to disclose
M. A. Socinski
Honoraria - Genentech; Lilly
Research Funding - Celgene; Genentech; Lilly; Pfizer; Synta
N. K. Veeramachaneni
No relevant relationships to disclose
B. E. Haithcock
No relevant relationships to disclose
W. K. Funkhouser
No relevant relationships to disclose
D. N. Hayes
No relevant relationships to disclose